ArticlePloS one2013

A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.

Chiori Yabuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.